Lenox Advisors Appoints Kristi Vassak as Chief Operating Officer
Long-term employee to take on expanded role that aligns well with her capabilities and relationships and the firm's growth objectives
NEW YORK,
Throughout her tenure with Lenox, Vassak has consistently elevated her leadership and impact while demonstrating a steadfast commitment to operational excellence. With this promotion, she will assume a pivotal role in driving the company's core vision forward, overseeing strategic initiatives, and scaling and streamlining operations. Vassak will focus on advancing efficiency and overall productivity, ensuring Lenox Advisors is well-positioned for continued success.
"This promotion reflects Kristi's exceptional leadership and her ability to drive better outcomes through collaboration, focus and accountability," said
Vassak has decades of experience in financial services, including 20 years with Lenox. She has navigated complex operational landscapes and consistently contributed to Lenox Advisors' success.
"Kristi empowers the firm to better serve our clients with innovative and comprehensive solutions," added Large. "Lenox Advisors continues to value strong leadership in our strategy to address the fast-evolving planning needs of clients. With Kristi leading our operations, we're confidently positioned for sustained excellence and growth."
About Lenox Advisors
Driven by the notion of what is best for you, Lenox Advisors builds custom solutions that integrate the financial needs of emerging affluent and other individuals with high net worth, their families, and corporate clients. As your advocate, we take the time to deeply understand your goals and values, informing our dynamic strategies to help protect and preserve your wealth. To learn more, visit www.lenoxadvisors.com.
CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/lenox-advisors-appoints-kristi-vassak-as-chief-operating-officer-302360790.html
SOURCE Lenox Advisors
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the
- Wallace Saunders Provides Notice of Data Incident
- Gates Industrial Announces Second-Quarter 2026 Earnings Release Date
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share